How a small worm may help the fight against Alzheimer's

March 14, 2014 by Sabine Dzuck
Image of a C. elegans roundworm. The blue fluorescence highlights the tissue producing most N-acetylglucosamine. Credit: MPI for the Biology of Ageing

(Medical Xpress)—Scientists at the Max Planck Institute for Biology of Ageing in Cologne have found that a naturally occurring molecule has the ability to enhance defense mechanisms against neurodegenerative diseases. Feeding this particular metabolite to the small round worm Caenorhabditis elegans, helps clear toxic protein aggregates in the body and extends life span.

During ageing, proteins in the human body tend to aggregate. At a certain point, protein aggregation becomes toxic, overloads the cell, and thus prevents it from maintaining normal function. Damage can occur, particularly in neurons, and may result in like Alzheimer's, Parkinson's or Huntington's disease. By studying model organisms like Caenorhabditis elegans, scientists have begun to uncover the mechanisms underlying neurodegeneration, and thus define possible targets for both therapy and prevention of those diseases. "Although we cannot measure dementia in worms", explains Martin Denzel of the Max Planck Institute for Biology of Ageing, "we can observe proteins that we also know from human diseases like Alzheimer's to be toxic by measuring effects on neuromuscular function. This gives us insight into how Alzheimer actually progresses on the molecular level".

Now, the scientists Martin Denzel, Nadia Storm, and Max Planck Director Adam Antebi have discovered that a substance called N-acetylglucosamine apparently stimulates the body's own against such toxicity. This metabolite occurs naturally in the organism. If it is additionally fed to the worm, "we can achieve very dramatic benefits", says Denzel. "It is a broad-spectrum effect that alleviates protein toxicity in Alzheimer's, Parkinson's and Huntington's disease models in the worm, and it even extends their ."

This molecule apparently plays a crucial role in quality control mechanisms that keep the body healthy. It helps the organism to clear toxic levels of protein aggregation, both preventing aggregates from forming and clearing already existing ones. As a result, onset of paralysis is delayed in models of neurodegeneration - How exactly the molecule achieves this effect is yet to be uncovered. "And we still don't know whether it also works in higher animals and humans", says Antebi. "But as we also have these metabolites in our cells, this gives good reason to suspect that similar mechanisms might work in humans."

Explore further: New understanding can lead to srategies for dealing with neurodegenerative diseases

More information: Martin S. Denzel, Nadia J. Storm, Aljona Gutschmidt, Ruth Baddi, Yvonne Hinze, Ernst Jarosch, Thomas Sommer, Thorsten Hoppe, and Adam Antebi. "Hexosamine pathway metabolites enhance protein quality control and prolong life." Cell, 13 March 2014

Related Stories

Anti-ageing hormone receptors

August 7, 2013

(Medical Xpress)—A reduced caloric intake increases life expectancy in many species. But how diet prolongs the lives of model organisms such as fruit flies and roundworms has remained a mystery until recently.

Recommended for you

Scientists convert skin cells into placenta-generating cells

October 12, 2015

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are ...

Genes linked with malaria's virulence shared by apes, humans

October 12, 2015

The malaria parasite molecules associated with severe disease and death—those that allow the parasite to escape recognition by the immune system—have been shown to share key gene segments with chimp and gorilla malaria ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.